RENN [Renren] 6-K: (Original Filing)

[Renren Announces Unaudited Fourth Quarter and Fiscal Year 2018 Financial Results BEIJING, China, May 14, 2019 — Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), which operates a leading premium used auto business in China (NASDAQ: KXIN) and several US-based SaaS businesses, today announced its ]

RENN [Renren] 6-K: (Original Filing)

[Renren Announces Unaudited Fourth Quarter and Fiscal Year 2018 Financial Results BEIJING, China, May 14, 2019 — Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), which operates a leading premium used auto business in China (NASDAQ: KXIN) and several US-based SaaS businesses, today announced its ]

RENN [Renren] 6-K: Renren Announces Unaudited Fourth Quarter and Fiscal Year

[Renren Announces Unaudited Fourth Quarter and Fiscal Year 2018 Financial Results BEIJING, China, May 14, 2019 — Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), which operates a leading premium used auto business in China (NASDAQ: KXIN) and several US-based SaaS businesses, today announced its ]

CBPO [China Biologic Products] 6-K: (Original Filing)

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

CBPO [China Biologic Products] 6-K: 18th Floor, Jialong International Building 19 Chaoyang Park

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

DHRM [Lianluo Smart] 20-F: (Original Filing)

[TABLE OF CONTENTS PART I Item 1. Identity of Directors, Senior Management and Advisers 1 Item 2. Offer Statistics and Expected Timetable 1 Item 3. Key Information 2 Item 4. Information on the Company 27 Item 4A. Unresolved Staff Comments 43 Item 5. Operating and Financial Review and Prospects 43 Ite]

Skip to toolbar